Who founded Oyster Point Pharma, Inc.?

Oyster Point Pharma, Inc. was founded by Jeffrey Nau in 2015.

Who are Oyster Point Pharma, Inc.'s investors?

Oyster Point Pharma, Inc.'s investors include Flying L Partners, New Enterprise Associates (NEA), Versant Venture AIV Holdings.

How much funding has Oyster Point Pharma, Inc. raised?

Oyster Point Pharma, Inc. has disclosed $113.6M raised across 2 rounds.

Where is Oyster Point Pharma, Inc. headquartered?

Oyster Point Pharma, Inc. is headquartered in San Francisco, US.

Oyster Point Pharma, Inc.

San Francisco, US · Founded 2015 · Delaware corporation · 3 known investors

A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments. Its offerings reference products such as a once-weekly combined hormonal contraceptive patch.

Biotech Healthtech

Founders & leadership

Oyster Point Pharma, Inc. was founded in 2015 by Jeffrey Nau.

Jeffrey NauFounder

Mark A. MurrayExecutive

D. Michael AckermannNamed on SEC filing

Board

William J LinkBoard directorManaging Partner at Flying L Partners

Ali Behbahani inBoard directorPartner, Co-Head of Healthcare at New Enterprise Associates (NEA)

Investors · 3

Flying L Partners

New Enterprise Associates (NEA)Menlo Park · $200K – $40Mvia Ali Behbahani · board

Versant Venture AIV HoldingsreportedSan Francisco

Reported raises · per SEC filings

Form D private placements

$113.6M disclosed across 2 rounds · 2017–2019

▶$85MraisedFeb 2019 · 7 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

William J LinkDirector
D. Michael AckermannDirector
Clare OzawaDirector
Benjamin TsaiDirector
Ali BehbahaniDirector
Jeffrey NauExecutive Officer, Director
Mark A. MurrayExecutive Officer, Director

Offering amount: $93M
Amount sold: $85M
First sale: Feb 2019
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$28.6MraisedOct 2017 · 8 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

D. Michael AckermannDirector
Mark A. MurrayExecutive Officer, Director
William J LinkDirector
Jeffrey NauExecutive Officer, Director
Ali BehbahaniDirector

Offering amount: $43.1M
Amount sold: $28.6M
First sale: Oct 2017
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Oyster Point Pharma, Inc. do?: A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments. Its offerings reference products such as a once-weekly combined hormonal contraceptive patch.
Who founded Oyster Point Pharma, Inc.?: Oyster Point Pharma, Inc. was founded by Jeffrey Nau in 2015.
Who are Oyster Point Pharma, Inc.'s investors?: Oyster Point Pharma, Inc.'s investors include Flying L Partners, New Enterprise Associates (NEA), Versant Venture AIV Holdings.
How much funding has Oyster Point Pharma, Inc. raised?: Oyster Point Pharma, Inc. has disclosed $113.6M raised across 2 rounds.
Where is Oyster Point Pharma, Inc. headquartered?: Oyster Point Pharma, Inc. is headquartered in San Francisco, US.